title: Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma.
authors.affiliation: Department of Clinical Hematology, Institute of Cancerology and Hematology, CHU Morvan, Brest, France. tempescul@hotmail.com
authors.forename: Adrian
authors.initials: A
authors.lastname: Tempescul
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Ianotto
authors.forename: Frederic
authors.initials: F
authors.lastname: Morel
authors.forename: Veronique
authors.initials: V
authors.lastname: Marion
authors.forename: Marc
authors.initials: M
authors.lastname: De Braekeleer
authors.forename: Christian
authors.initials: C
authors.lastname: Berthou
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000235:genetics; D012008:Recurrence; D012074:Remission Induction; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide